Browse our news

NTU is delighted to be a Bronze Charity Partner for the Robin Hood Half Marathon 2025, with a wonderful group of 17 fundraisers already pledged to run the 21km route through Nottingham.

ntu.ac.uk/about-us/news/news-articles/2025/04/karen-goes-the-distance-in-support-of-the-john-van-geest-cancer-research-centre

A team of Robin Hood Half Marathon runners fundraised over £3000 for The John van Geest Cancer Research Centre at Nottingham Trent University.

ntu.ac.uk/about-us/news/news-articles/2024/12/ntus-robin-hood-half-marathon-runners-raise-over-3000-for-the-john-van-geest-cancer-research-centre

The John van Geest Cancer Research Centre (JvGCRC) has recently acquired Emulate’s Organ-Chip technology, which will enable our researchers to recreate human biology within a microphysiological environment.

ntu.ac.uk/about-us/news/news-articles/2023/04/new-technology-at-the-john-van-geest-cancer-research-centre

Interview with John van Geest Cancer Research Centre donor, Dominic Hayer.

ntu.ac.uk/about-us/news/news-articles/2022/03/meet-one-of-our-donors-dominic-hayer

A single bout of exercise triggers processes in bone cells which could help to protect against the spreading of cancer to the bones, a new study suggests.

ntu.ac.uk/about-us/news/news-articles/2021/06/exercise-prompts-cells-to-react-in-a-way-that-could-protect-against-bone-cancer-and-other-bone-related-illnesses,-research-suggests-to-react-in-a-way-that-could-protect-against-bone-cancer-and-other-bone-related-illnesses,-research-suggests

Scientists at the University of Nottingham and Nottingham Trent University are to begin clinical trials for a DNA vaccine to prevent COVID-19.

ntu.ac.uk/about-us/news/news-articles/2020/08/funding-will-allow-clinical-trials-for-covid-19-vaccine-to-begin-in-nottingham

Scientists have identified a gene which if present in certain breast cancer patients indicates how they will respond to specific therapies.

ntu.ac.uk/about-us/news/news-articles/2020/08/gene-could-guide-better-treatment-of-most-common-breast-cancer

A new blood test developed by scientists and clinicians is able to detect the presence of prostate cancer and confirm how advanced it is.

ntu.ac.uk/about-us/news/news-articles/2020/07/new-blood-test-can-confirm-prostate-cancer-and-what-stage-it-is-at

A new study will enable clinicians to identify patients with aggressive leukaemia who will not respond to chemotherapy and those who are most likely to benefit from a new immunotherapy.

ntu.ac.uk/about-us/news/news-articles/2020/06/study-paves-way-for-faster,-more-accurate-therapies-for-hard-to-treat-leukaemia-patients

Scientists at the University of Nottingham and Nottingham Trent University will contribute essential virology expertise to help develop a safe and effective vaccine to prevent COVID-19.

ntu.ac.uk/about-us/news/news-articles/2020/04/universities-in-nottingham-to-play-a-key-role-in-the-development-of-a-potential-dna-vaccine-against-covid-19